Sygnis Pharma

TGR BioSciences Pty Ltd (TGR) is a private company located in Adelaide, Australia. Established in 2001, TGR is committed to providing innovative solutions for cell-based research applications. Their scientists have expertise in cell biology, biochemistry and immunoassay design, and have developed products and services of the highest quality, which have been used successfully in drug discovery programs around the world.

Innova Biosciences Ltd. develops antibody labeling and bioconjugation kits for the life science sector. It offers antibody labeling kits, such as enzyme, fluorescent protein, biotin/streptavidin, tandem, and fluorescent dye labeling kits. The company also provides rapid antibody labeling kits, rapid fluorescent dye labeling kits, antibody purification kits, gold conjugation kits, immunogen kits, maleimide activated labels, substrates and stabilizers, phosphate detection assays, and affinity resins. Its products are used in hospital, research, and pharmaceutical research and development labs; immunodiagnostic applications; and consumer items, such as pregnancy test kits. The company offers its products through a distributor network globally, as well as online. Innova Biosciences Ltd. was founded in 2002 and is based in Cambridge, United Kingdom. As of June 21, 2017, Innova Biosciences Ltd. operates as a subsidiary of Sygnis AG.

Expedeon is an expert in cutting-edge innovative reagents and services for life sciences and diagnostics, with application across workflows including: protein electrophoresis; liquid biopsy; whole genome amplification; antibody- and protein-labeling; and immunoassay development. Our cutting-edge offerings include off-the-shelf products, and custom services, supporting scientists from academia through to commercial manufacturing across the life sciences and diagnostic industry. Expedeon’s dedicated team of experts has the flexibility to develop and supply consistently high quality products both off-the-shelf and to customer specification. We are constantly innovating to provide high quality, easy-to-use, cost-effective solutions, to minimize hands-on time for researchers. All our products are stringently QC tested, and are designed to save scientists time and costs. Expedeon is wholly owned by SYGNIS AG and has laboratory facilities and commercial sites in the UK, USA, Singapore, Germany and Spain. Expedeon provides fast, global delivery. Off-the-shelf products are available with next-day delivery and quick turnaround times are offered on custom product generation.

C.B.S. has developed a strong global brand in electrophoresis equipment and scientific instrumentation for genomics and proteomics research. At C.B.S., products are engineered for versatility, optimal performance and ease of use. The company’s product offering is highly complementary to SYGNIS’ product ranges and includes a wide variety of electrophoresis systems as well as DNA mutation detection systems and DNA workstations to provide a contaminant free environment for DNA amplification.

Amnestix, Inc. is a biopharmaceutical company working on cognitive enhancement. The company focuses on novel therapeutics for improving memory associated with a variety of human diseases. It also builds a pipeline of compounds, which are cognitive enhancers. The company was founded in 2006 and is based in Burlingame, California. As of June 8, 2008, Amnestix Inc. operates as a subsidiary of Sygnis Pharma AG.